Redcare Pharmacy earned significantly more in the second quarter of 2025 than in the same period last year.
The adjusted result before interest, taxes and depreciation (EBITDA) rose to 18.1 million euros from 15 million euros in the same period in the previous year. With 2.6 percent, however, the corresponding margin was slightly below the previous year’s value of 2.7 percent. The bottom line was that there was a group profit of 8.9 million euros. A one-time effect of 14.2 million euros in connection with the successful convertible bond transactions in April was positive, as the online pharmacy announced.
CEO Olaf Heinrich said “very satisfied” with the company’s performance.
The number of active customers rose by 0.4 million to 13.5 million euros in the second quarter. In the middle of the year, the customer base was 1.9 million above the previous year’s value.
Redcare Pharmacy had already confirmed the annual forecast at the beginning of the month when submitting preliminary sales figures. Group sales rose by 26.4 percent to 709 million euros from April to June, primarily due to the increase in sales with medicines on a prescription (RX). For the year 2025, the company is aiming for an adjusted EBITDA margin of 2 to 2.5 percent. Sales should increase by at least 25 percent. The RX turnover in Germany is seen at over 500 million euros.
In the meantime, customers may also look forward to price reductions at the online pharmacy in the future: “The latest judgment of the Federal Court of Justice strengthens our position to continue to offer bonuses on prescription drugs,” said Redcare-Lenker Heinrich. This is how Redcare reacts similarly to the BGH judgment in mid-July, similar to competitor Docmorris, to grant customers a bonus when ordering online for prescription drugs.
The BGH had decided that a Dutch pharmacy, which was now integrated into the DocMorris group, was allowed to lure customers in Germany more than ten years ago when selling prescription drugs with bonuses. A long-term legal dispute had preceded whether the price commitment also applies to mail order pharmacies in other EU countries, which already employed the European Court of Justice (ECJ) and other courts in this country. In this context, the regulations valid in Germany were also revised.
However, the interpretation of the BGH judgment, which refers to the old rules, is controversial. The Federal Association of German Pharmacists’ Associations (ABDA) has made it clear that it assumes that the price is retained for prescription medicines in Germany. Federal Minister of Health Nina Warken (CDU) recently announced that the newspapers of the Funke media group recently announced that she would protect the price commitment.
In Xetra trading, the Redcare Pharmacy share temporarily gains 0.57 percent to EUR 106.50. The day before, the course had fallen by almost six percent. And even in the course of the year, the share put a rather bumpy ride, including concerns about the E-Recipe Cardlink Cardlink, the stock had fallen to a two-year low at the end of June, from which it has not yet completely recovered. The minus is almost 19 percent over the year.
Dow Jones / DPA-AFX
Selected leverage products on Redcare Pharmacy (Ex Shop Pharmacy)
With knock-outs, speculative investors can participate disproportionately in price movements. Simply choose the desired lever and we will show you suitable open-end products on Redcare Pharmacy (Ex Shop Pharmacy)
The lever must be between 2 and 20
Advertising